9th DDR Inhibitors Summit

Returning to Boston for its 9th year, the DDR Inhibitors Summit is the definitive industry forum for drug developers advancing DNA Damage Response (DDR)-targeted therapies. With PARP inhibitors now clinically validated, the field is rapidly evolving to explore novel DDR targets like ATR, CHK1/2, DNA-PK, and WEE1, alongside smarter biomarker strategies and combination approaches. This year’s summit is your opportunity to stay ahead of the curve. Across three content-rich days, you’ll uncover translational breakthroughs, hear from biotech innovators & academic pioneers, and gain strategic insights to overcome resistance, enhance selectivity, and accelerate clinical success. With the DDR landscape rapidly expanding, now is the time to connect, collaborate, and shape the future of targeted oncology.

Event Links

Website: https://go.evvnt.com/3289243-0

Tickets: https://go.evvnt.com/3289243-1

Brochure: https://go.evvnt.com/3289243-3

Read More

View Less